Trial intelligence / Profile preview

BQ-123 in On-pump Coronary Artery Bypass Grafting

NCT01658410Phase 2Unknown

Sponsor
Medical University of Vienna
Start
Jul 2012
Primary completion
Dec 2015
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of BQ-123 in coronary artery disease (CAD), sponsored by Medical University of Vienna. Status: unknown.

02

Drugs

BQ-123
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT01658410.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01658410.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call